Nolatrexed
- Level
- Commodity
- Parent
- 51111600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51111647This classification denotes a thymidylate synthase inhibitor and folate antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K75ZUN743Q. European Medicines Agency schedules Nolatrexed in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09342MIG. Nolatrexed generally arises in the molecular formula C14H12N4OS. The term NOLATREXED is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) NOLATREXED is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nolatrexed under HS 29335995 and SITC 51576. As of Q4 2014, NOLATREXED remains the US FDA Preferred Term for this commodity. SMILES: S(C1C2C([NH]C(NC2=O)N)CCC1C)C1CCNCC1.
Same parent
Under 51111600 · 55Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.